The ultra-short-acting opioid remifentanil could theoretically be a safer induction agent with less risk of aspiration than neuromuscular blockers like succinylcholine or rocuronium.
Can remifentanil replace neuromuscular block…
The ultra-short-acting opioid remifentanil could theoretically be a safer induction agent with less risk of aspiration than neuromuscular blockers like succinylcholine or rocuronium.